Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05705193 · ClinicalTrials.gov registry record · NA
Brain-Training Treatment for Long COVID in Older Adults
A NA study of Post-Acute COVID-19 Syndrome, sponsored by UConn Health.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05705193: Recruiting NA study of Post-Acute COVID-19 Syndrome, sponsored by UConn Health.
NCT05705193 is a NA study of Post-Acute COVID-19 Syndrome that is actively recruiting participants, run by UConn Health. The registered enrollment target is 40 participants, below the 841-participant average among 14 other Post-Acute COVID-19 Syndrome trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05705193, a NA study of Post-Acute COVID-19 Syndrome, is actively recruiting participants, sponsored by UConn Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This research is being done to collect preliminary data on the potential of computerized "brain-training" exercises for treating Long COVID symptoms in older adults. The investigators hypothesize that computerized brain-training will be an acceptable and feasible intervention for treating Long COVID symptoms in older adults. The investigators also expect to provide initial evidence that computerized brain-training has potential for improving thinking, mood, and other aspects of everyday functioning in older adults with Long COVID.
Primary Outcome
Treatment acceptability and adherence as measured by the TAAS Total Score; higher scores on this self-report measure indicate greater treatment acceptability and adherence
Conditions Studied
Interventions
- OTHER NeuroFlex (computerized gamified tasks)
Study Locations (1)
Connecticut
- UConn Health - Farmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-04-07 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT05705193 shows while recruiting
NCT05705193 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 841-participant average among 14 other Post-Acute COVID-19 Syndrome trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Post-Acute COVID-19 Syndrome appearing as the primary indexed condition, and to 1 intervention - of which NeuroFlex (computerized gamified tasks) is the first listed.
NCT05705193 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT05705193 about?
NCT05705193 is a clinical study titled "Brain-Training Treatment for Long COVID in Older Adults". This research is being done to collect preliminary data on the potential of computerized "brain-training" exercises for treating Long COVID symptoms in older adults. The investigators hypothesize that computerized brain-training will be an acceptable and feasible intervention for treating Long COVID...
What is the current status of trial NCT05705193?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-04-07. Estimated completion is 2026-06-30.
What conditions does trial NCT05705193 study?
This clinical trial studies the following conditions: Post-Acute COVID-19 Syndrome.
What interventions are being tested in trial NCT05705193?
The interventions under investigation include: NeuroFlex (computerized gamified tasks) (OTHER).
Who is sponsoring clinical trial NCT05705193?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05705193 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-Acute COVID-19 Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05705193's enrollment target sits among peer trials
40 11th of 14 higher than 4 of 14 other Post-Acute COVID-19 Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post-Acute COVID-19 Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Long-Covid-19 Alleviation Through Learning Mindfulness Study
RECRUITING · NA
-
Long COVID Brain Fog: Cognitive Rehabilitation Trial
RECRUITING · NA
-
Care for Veterans Post-COVID-19
RECRUITING · NA
-
Dietary Intervention to Mitigate Post-Acute COVID-19 Syndrome
RECRUITING · NA
-
Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome
RECRUITING · NA
-
A Study of Positive Emotions With Long COVID-19
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI